Eventide Asset Management LLC Increases Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Eventide Asset Management LLC increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 979.2% in the third quarter, Holdings Channel reports. The firm owned 822,438 shares of the company’s stock after acquiring an additional 746,231 shares during the period. Eventide Asset Management LLC’s holdings in Privia Health Group were worth $14,977,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. boosted its position in Privia Health Group by 402.9% during the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after purchasing an additional 143,446 shares during the period. GAMMA Investing LLC boosted its position in Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after buying an additional 845 shares during the last quarter. Peregrine Capital Management LLC raised its stake in shares of Privia Health Group by 11.5% in the 2nd quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock valued at $5,461,000 after purchasing an additional 32,311 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Privia Health Group in the 3rd quarter valued at about $1,206,000. Finally, BlackBarn Capital Partners LP raised its stake in shares of Privia Health Group by 100.0% in the 2nd quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock valued at $6,952,000 after purchasing an additional 200,000 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on PRVA shares. KeyCorp started coverage on shares of Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price on the stock. Truist Financial upped their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Robert W. Baird increased their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 26th. Barclays increased their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Two analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Privia Health Group has an average rating of “Buy” and an average target price of $25.07.

Insider Buying and Selling

In related news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares in the company, valued at approximately $4,583,763.50. This trade represents a 35.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 14.20% of the stock is currently owned by insiders.

Privia Health Group Price Performance

Privia Health Group stock opened at $21.66 on Friday. The firm has a 50 day simple moving average of $19.14 and a 200-day simple moving average of $18.65. The stock has a market capitalization of $2.60 billion, a PE ratio of 216.62, a price-to-earnings-growth ratio of 5.45 and a beta of 0.76. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $24.30.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.